Phenomic Medicine and Metabolic Disease Trajectories: Measuring and Modelling the Health to Disease Continuum

Abstract

Abstract Phenomic medicine is an emerging field that involves measurement and modelling of multidimensional phenotypic data to provide a systems-level framework to understand how health and disease evolve over time and inform decision making in a clinical context . Unlike genomic medicine, which is largely predictive of predisposition, phenomic medicine captures the dynamic biochemical, physiological, and metabolic changes that occur across the disease continuum. Metabolic profiling, imaging, digital health data, and electronic health records can be used to characterise these phenotypic shifts longitudinally by constructing temporal models that map disease trajectories at both individual and population-wide scales. Phenomic trajectories allow for the stratification of patients based on the evolving pathobiology arising from gene-environment interactions that underpin disease progression, resilience, or recovery. The modelling of these trajectories can identify early markers of transition from health to subclinical dysfunction, establish critical inflection points, and distinguish reversible versus irreversible stages of disease. This capability is particularly powerful in complex, multifactorial conditions such as cardiovascular disease, diabetes, or post-viral syndromes, where a simple panel of biomarkers established in cross-sectional cohort studies lacks the required specificity for prognostic precision. Ultimately, phenomic medicine offers a route to transforming care from a reactive to a proactive mode, and can support personalised health management across the life course.